Montgomery, Alabama is preparing for the opening of its first medical cannabis dispensary, Callie’s Apothecary, marking a significant development in patient access within the state. The dispensary is expected to commence operations in the coming days, following the completion of product testing, according to a May 14, 2026 report by WVTM 13 News.
This opening represents a further step in Alabama’s medical cannabis program, which has previously seen the registration of physicians authorized to recommend medical cannabis and the awarding of business licenses to cultivators and processors, as reported by Hemp Gazette.
Advancing Medical Cannabis Access in Alabama
The establishment of Callie’s Apothecary completes the supply chain necessary for patients to obtain medical cannabis products. The process begins with licensed growers, such as Antoine Mordican, who cultivate the cannabis plants. These plants are then sold to processors, including Homestead Health in Jasper, which transforms the raw material into various medical cannabis products.
- Cultivation: Growers like Antoine Mordican initiate the supply chain.
- Processing: Facilities such as Homestead Health convert raw cannabis into finished products.
- Dispensing: Callie’s Apothecary will be the final point of sale to eligible patients.
These processed products, which include tablets, gummies, and tinctures, will then be available at the medical cannabis dispensary for patients who have obtained a medical cannabis card through a certified physician.
Dispensary Operations and Patient Experience
Vince Schilleci, an owner of Callie’s Apothecary, indicated that the dispensary aims to serve an anticipated 250 patients within its first week of operation. The facility is designed to offer patients a choice in how they ingest their products, with various forms available. Schilleci stated that while the product containing THC remains consistent, the method of consumption varies.
Eligibility for medical cannabis in Alabama requires patients to have a qualifying condition. Schilleci identified depression, chronic pain, and terminal illness as three primary areas expected to drive patient demand. Alora Frank, the dispensary’s area manager, who has prior experience in Florida’s medical cannabis industry, expressed an objective to facilitate patient access to these therapeutic options.
Pricing and Coverage
Regarding product pricing, Schilleci noted efforts to maintain reasonable costs. For example, 100 mg of THC is expected to be priced under US$60. It is important for patients to note that medical insurance will not cover the cost of medical cannabis products in Alabama.
Regulatory Context and Market Outlook
The opening of Callie’s Apothecary signifies the operationalization of the state’s medical cannabis framework. While Alabama has issued medical cannabis cards to some residents, the complete process for patients to acquire products has been pending the opening of dispensaries. This development provides a tangible point of access for patients who have navigated the initial stages of physician consultation and card acquisition.
For a period, Callie’s Apothecary is projected to be the sole medical cannabis retail outlet in Alabama. This limited initial access suggests that patients from various parts of the state may travel to Montgomery to obtain their prescribed products, as indicated by the dispensary’s management.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
